查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439228

血糖监测系统 - 全球市场考量、竞争格局、市场预测 (2030)

Blood Glucose Monitoring Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球血糖监测系统市场规模预计2023年将达到130.6亿美元，2030年将达到204亿美元，2024-2030年预测期间复合年增长率为7.72%。血糖监测系统的需求不断增加，主要是由于世界各地糖尿病盛行率不断上升，以及人口老化负担日益加重，更容易出现高血糖。此外，利用先进技术的血糖监测设备产品的激增以及政府为提高人们对适当糖尿病管理的认识而采取的举措，都是可能推动全球血糖监测系统市场的因素。

血糖监测系统市场动态

由于全球人口中糖尿病盛行率的不断上升，血糖监测系统市场目前正在蓬勃发展。根据International Diabetes Federation Atlas Ninth（2019）的数据，2019年全球约有4.63亿20岁至79岁的成年人患有糖尿病，预计到2045年这一数字将增加至7亿。

上述资料也指出，约有 110 万名儿童和青少年患有第 1 型糖尿病，约 2,000 万名活产婴儿（六分之一的活产婴儿）在怀孕期间受到糖尿病的影响。因此，正确管理糖尿病需要适当的血糖监测，这将增加预测期内对血糖监测系统的需求。

此外，老年人口的增加更容易患糖尿病，预计将增加对血糖监测系统的需求。根据United Nations World Population Ageing 2019显示，2019年，全球65岁以上人口数量约为7.03亿，到2050年，老年人数量预计将翻一番，达到15亿。此外，根据American Diabetes Association 2022年的数据，2018年美国65岁以上老年人罹患糖尿病的比例为26.8%，美国有1,430万老年人患有糖尿病，且处于较高水准。

此外，采用先进技术的血糖监测系统的批准也有望快速成长血糖监测系统的市场。例如，2020 年 9 月 28 日，Abbott的下一代系统 FreeStyle Libre 3 获得了 CE 标誌，该系统由世界上最小、最薄的传感器组成，可自动向智慧型手机提供连续、实时的血糖水平。

因此，所有上述因素预计将在预测期内对血糖监测系统市场做出贡献。

然而，与血糖监测系统相关的高成本可能会限制市场。

史无前例的 COVID-19 大流行对血糖监测系统的影响有限。这是因为 FDA 在 COVID-19 大流行期间发布了关于在医院使用家用血糖仪的指南，这可以促进远端患者监测。此外，由于全国范围内的封锁、需求疲软和后勤方面的挑战，在COVID-19 紧急情况期间将连续血糖监测系统的使用范围扩大到住院患者，使医院工作人员能够远端监测患者的血糖，也是一项挑战。儘管供应链受到限制，但仍适用于血糖监测系统。

血糖监测系统市场细分分析

在血糖监测系统产品领域，连续血糖监测系统（CGM）预计将在预测期内占据重要的市场份额。这是因为 CGM 系统提供有关血糖水平趋势的即时动态信息，而不是单一读数，以改善血糖控制，这一优势可能会增加对这些系统的需求。这是因为它高度敏感。

本报告研究和分析了全球血糖监测系统市场，提供市场规模和预测、驱动因素和挑战、公司和产品概况等。

目录

第一章血糖监测系统市场报告简介

第二章血糖监测系统市场概要

  • 调查范围
  • 市场概况
  • 竞争评估
  • 财务基准

第三章 法规与专利分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章血糖监测系统市场关键因素分析

  • 血糖监测系统市场的驱动因素
    • 糖尿病盛行率增加
    • 增加老年人的负担
    • 各种血糖监测系统的核准增加
    • 产品技术进步迅速
  • 血糖监测系统市场的限制与挑战
    • 血糖监测系统成本高
    • 新兴国家诊断和治疗率下降可能会限制血糖监测系统的采用
  • 血糖监测系统市场机会
    • 大公司旨在扩大市场的策略性业务活动也提供了成长机会。
    • 政府加大力度提高低收入和中等收入国家的意识可能会为市场创造机会

第五章血糖监测系统的波特五力分析

第六章 COVID-19对血糖监测系统市场的影响分析

第七章血糖监测系统市场布局

  • 按产品类型
    • 血糖自我监测系统
    • 连续血糖监测系统
  • 按方式
    • 可穿戴
    • 不可穿戴
  • 按最终用户
    • 医院
    • 居家护理环境
    • 其他
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第八章血糖监测系统：全球公司份额分析－3至5家主要公司

第九章 血糖监测系统公司及产品简介

  • Medtronic
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • LifeScan IP Holdings (Johnson & Johnson)
  • Dexcom Inc.
  • ARKRAY, Inc.
  • Senseonics
  • WaveForm Technologies, Inc.
  • B. Braun Melsungen AG
  • Ascensia Diabetes Care Holdings AG.
  • Ypsomed
  • i-SENS, Inc.
  • Intuity Medical, Inc.
  • ACON Laboratories, Inc.
  • Prodigy Diabetes Care, LLC
  • Sinocare
  • Rossmax International Ltd.
  • Menarini Diagnostics s.r.l
  • Bionime Corporation.
  • Nemaura.

第10章 KOL观点

第十一章专案方法

第 12 章. 关于 DelveInsight

第十三章 免责声明与联络我们

Product Code: DIMDCL0013

Blood Glucose Monitoring Systems Market By Product Type (Self-Monitoring Blood Glucose Systems And Continuous Glucose Monitoring Systems), By Modality (Wearable And Non-Wearable), By End-User (Hospitals, Home Care Settings, And Others), by geography, is expected to expand at a noteworthy CAGR till 2030 owing to the growing prevalence of diabetes across the globe and technological advancements in the blood glucose monitoring systems.

The global blood glucose monitoring systems market was valued at USD 13.06 billion in 2023, growing at a CAGR of 7.72% during the forecast period from 2024 to 2030, in order to reach USD 20.40 billion by 2030. The escalating demand for blood glucose monitoring systems is predominantly attributed to the increasing prevalence of diabetes among the population across the globe, the growing burden of the geriatric population who are susceptible to developing hyperglycemia. In addition, the spike in technologically advanced blood glucose monitoring devices product launch and government initiatives to raise awareness regarding proper diabetes management, among others are the factors likely to spur the global blood glucose monitoring systems market.

Blood Glucose Monitoring Systems Market Dynamics:

The market for blood glucose monitoring systems is gaining momentum at present owing to the increasing prevalence of diabetes among the worldwide population. According to the International Diabetes Federation Atlas Ninth edition 2019, approximately 463 million adults aged between 20-79 years of age were living with diabetes across the globe in the year 2019 which is expected to rise to 700 million by the year 2045.

The above-mentioned source also stated that about 1.1 million children and adolescents are living with type I diabetes and around 20 million live births (1 in 6 live births) are affected by diabetes during pregnancy. Thus, for adequate management of diabetes, proper blood glucose monitoring is necessary which increases the demand for blood glucose monitoring systems during the forecasted period.

Also, the growing geriatric population who are susceptible to developing diabetes is expected to raise the demand for blood glucose monitoring systems. According to the United Nations World Population Ageing 2019 highlights, there were about 703 million persons aged 65 years or over in the world in the year 2019, and the number of older persons is projected to double to 1.5 billion by the year 2050. Moreover, as per the American Diabetes Association 2022 data, the percentage of Americans age 65 and older with diabetes remained high, at 26.8%, or 14.3 million seniors in the US in the year 2018.

In addition, approval of technologically advanced blood glucose monitoring systems is also anticipated to surge the market for blood glucose monitoring systems. For instance, on September 28, 2020, Abbott secured the CE mark for its next-generation FreeStyle Libre 3 system, comprising the world's smallest, thinnest sensor and delivers continuous and real-time glucose readings automatically to smartphones.

Hence, all the aforementioned factors are expected to contribute to the blood glucose monitoring systems market during the forecasted period.

However, the high cost associated with the blood glucose monitoring systems is likely to impede the market.

The unprecedented COVID-19 pandemic has a limited effect on the blood glucose monitoring system. This is because the issuance of FDA guidelines for using home-use blood glucose meters in hospitals during the COVID-19 pandemic can facilitate remote patient monitoring. Moreover, extended use of continuous glucose monitoring systems to hospitalized patients during the COVID-19 emergency to allow hospital staff to remotely monitor glucose in patients also boost the demand for the glucose monitoring systems despite nationwide lockdowns, sluggish demand, and supply chain due to logistical restrictions.

Blood Glucose Monitoring Systems Market Segment Analysis:

Blood Glucose Monitoring Systems Market By Product Type (Self-Monitoring Blood Glucose Systems and Continuous Glucose Monitoring Systems), By Modality (Wearable and Non-Wearable), By End-User (Hospitals, Home Care Settings, and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Blood Glucose Monitoring Systems product segment, continuous glucose monitoring systems (CGM) are anticipated to hold a significant market share during the forecasted period. This is because the advantage of providing real-time and dynamic information about the trends of the glucose levels unlike a single reading exhibited by the CGM systems for improved glycemic control is likely to raise the demand for these systems.

Additionally, the rise in key market players' initiative toward the development of advanced CGM systems for diabetic patients for proper diabetes care and management is further expected to grow the market for CGM systems. For instance, on February 11, 2020, Senseonics Holdings, Inc., a medical technology company focused on the development of implantable continuous glucose monitoring (CGM) system entered into an agreement with Companion Medical to integrate Eversense® CGM System real-time glucose data with the Companion Medical InPen(TM) smart system for insulin delivery.

Also, on April 05, 2019, WaveForm Technologies, Inc. a wholly-owned subsidiary of WaveForm Diabetes (formerly AgaMatrix Holdings, LLC) and developer of novel products for continuous glucose monitoring entered into a partnership with A. Menarini Diagnostics S.r.l. to commercialize the WaveForm Technologies Continuous Glucose Monitor (CGM).

Furthermore, the product launch of the continuous glucose monitoring system for people with gestational diabetes is also projected to spike the segmental growth of the blood glucose monitoring systems. For instance, in November 2020, Abbott, launched the FreeStyle® Libre system for adults and children (above the age of four) living with diabetes in India and women with gestational diabetes (diabetes during pregnancy).

Thus, all the above-mentioned factors are likely to upsurge the market for blood glucose monitoring systems.

North America is expected to dominate the Overall Blood Glucose Monitoring Systems Market:

Among all the regions, North America is expected to hold a major share in the overall blood glucose monitoring systems market during the forecasted period. This domination is owing to the rising burden of the diabetic population in the region. Moreover, the increasing prevalence of obesity in the region which accounts for between 80 and 85% of the risk of developing type 2 diabetes is also anticipated to raise the demand for blood glucose monitoring systems in the coming years. In addition, the rising adoption of technologically advanced glucose monitoring systems, and rigorous glucose monitoring product approvals and launches in the region for better diabetes management also contribute to the regional blood glucose monitoring systems market.

For instance, according to the Centres for Disease Control and Prevention (CDC) 2020 data, about 34.2 million Americans have diabetes. The data also mentioned that out of the total diabetic population in the region 15% were smokers, 89% were overweight, and 38% were physically inactive.

In addition, according to the data published by Diabetes Canada, a national health charity, in the year 2020, approximately 11 million Canadians are living with diabetes or prediabetes. Thus, the surge in the diabetic population in the region will boost the demand for blood glucose monitoring systems.

Furthermore, a rise in blood glucose monitoring product launches in the region will also lead to the growth of the glucose monitoring systems market in the region. For instance, in November 2022, Intuity Medical launched the POGO Automatic Blood Glucose Monitoring System for diabetes patients in the US.

Hence, all the above-stated factors are expected to propel the blood glucose monitoring systems market in the region.

Also, the APAC region has future potential for the blood glucose monitoring systems market. This is owing to the rising burden of the targeted population in the region, the growing geriatric population. Moreover, the continuous efforts by the leading companies to introduce continuous glucose monitoring systems in the region will also fuel the blood glucose monitoring systems market. For instance, on July 27, 2022, Terumo launched the Dexcom G6 Continuous Glucose Monitoring (CGM) System in Japan, which is manufactured by Dexcom, Inc. Also, in the year 2019, Medtronic partnered with Handok to market and distribute Medtronic's Guardian Connect and iPro 2 continuous glucose monitoring system in South Korea.

In addition, improved healthcare infrastructure, and increasing disposable income in the region will also boost the blood glucose monitoring systems market in the region.

Blood Glucose Monitoring Systems Market Players:

Some of the key market players operating in the Blood Glucose Monitoring Systems market include Medtronic, Abbott, F. Hoffmann-La Roche Ltd, LifeScan IP Holdings (Johnson & Johnson), Dexcom Inc., ARKRAY, Inc., Senseonics, WaveForm Technologies, Inc., B. Braun Melsungen AG, Ascensia Diabetes Care Holdings AG., Ypsomed, i-SENS, Inc., Intuity Medical, Inc., ACON Laboratories, Inc., Prodigy Diabetes Care, LLC, Sinocare, Rossmax International Ltd., A. Menarini Diagnostics s.r.l, Bionime Corporation., MEDISANA GMBH, Nemaura., and others.

Recent Developmental Activities in the Blood Glucose Monitoring Systems Market:

On August 24, 2022, Smart Meter, the leader in cellular-connected remote patient monitoring (RPM) devices, data, and services, announced the availability of its iGlucose monitor for managing gestational diabetes.

On February 19, 2020, DexCom, Inc. and Insulet Corporation entered into a commercialization agreement to combine current and future Dexcom continuous glucose monitoring systems (CGM) with Insulet's trusted tubeless insulin delivery Pod into the Omnipod Horizon(TM) System for automated insulin delivery, currently in the pivotal trial.

On February 19, 2020, Abbott and Insulet Corporation partnered to integrate Abbott's world-leading continuous glucose sensing technology with Insulet's next-generation tubeless system, the Omnipod Horizon(TM) Automated Insulin Delivery (AID) System (Omnipod Horizon System), to offer personalized automated insulin delivery and care for people living with diabetes.

Key Takeaways from the Blood Glucose Monitoring Systems Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Blood Glucose Monitoring Systems market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Blood Glucose Monitoring Systems Market.

Various opportunities available for the other competitor in the Blood Glucose Monitoring Systems Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Blood Glucose Monitoring Systems market growth in the coming future?

Target Audience who can be benefited from the Blood Glucose Monitoring Systems Market Report Study

Blood Glucose Monitoring Systems providers

Research organizations and consulting companies

Blood Glucose Monitoring Systems-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Blood Glucose Monitoring Systems

Various End-users who want to know more about the Blood Glucose Monitoring Systems Market and the latest technological developments in the Blood Glucose Monitoring Systems market.

Frequently Asked Questions for the Blood Glucose Monitoring Systems Market:

1. What are Blood Glucose Monitoring Systems?

Blood glucose monitoring systems are used at home or in health care settings to measure/monitor the amount glucose level in the blood. There are two types of blood glucose monitors available in the market - self-monitoring blood glucose monitoring systems and continuous glucose monitoring systems.

2. What is the market for Global Blood Glucose Monitoring Systems?

The global blood glucose monitoring systems market was valued at USD 13.06 billion in 2023, growing at a CAGR of 7.72% during the forecast period from 2024 to 2030, in order to reach USD 20.40 billion by 2030.

3. What are the drivers for the Global Blood Glucose Monitoring Systems?

The major factors driving the demand for Blood Glucose Monitoring Systems are the growing prevalence of diabetes among the worldwide population. Moreover, technological advancement in the product portfolio, growing geriatric population, and rising government initiatives to raise awareness regarding proper diabetes management are also expected to boost the market.

4. What are the key players operating in Global Blood Glucose Monitoring Systems?

Some of the key market players operating in the Blood Glucose Monitoring Systems market include Medtronic, Abbott, F. Hoffmann-La Roche Ltd, LifeScan IP Holdings (Johnson & Johnson), Dexcom Inc., ARKRAY, Inc., Senseonics, WaveForm Technologies, Inc., B. Braun Melsungen AG, Ascensia Diabetes Care Holdings AG., Ypsomed, i-SENS, Inc., Intuity Medical, Inc., ACON Laboratories, Inc., Prodigy Diabetes Care, LLC, Sinocare, Rossmax International Ltd., A. Menarini Diagnostics s.r.l, Bionime Corporation., MEDISANA GMBH, Nemaura., and others.

5. Which region has the highest share in the Blood Glucose Monitoring Systems market?

Among all the regions, North America is expected to hold a major share in the overall blood glucose monitoring systems market during the forecasted period, 2024-2030. This domination is owing to the rising burden of the diabetic population in the region. Moreover, the increasing prevalence of obesity in the region which is the major risk factor for developing type 2 diabetes is also anticipated to raise the demand for blood glucose monitoring systems in the coming years. In addition, the rising adoption of technologically advanced glucose monitoring systems, and rigorous glucose monitoring product approvals and launches in the region for better diabetes management also contribute to the regional blood glucose monitoring systems market.

Table of Contents

1.Blood Glucose Monitoring Systems Market Report Introduction

2.Blood Glucose Monitoring Systems Market Executive summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Blood Glucose Monitoring Systems Market Key factors analysis

  • 4.1 Blood Glucose Monitoring Systems Market Drivers
    • 4.1.1 Growing prevalence of diabetes
    • 4.1.2 The increasing burden of the old age population
    • 4.1.3 Rise in approval of various Blood Glucose Monitoring Systems
    • 4.1.4 Rapid technological advancement in the products
  • 4.2 Blood Glucose Monitoring Systems Market Restraints and Challenges
    • 4.2.1 High cost of the Blood Glucose Monitoring Systems
    • 4.2.2 Lower diagnosis and treatment rates in emerging nations may restrict blood glucose monitoring systems adoption
  • 4.3 Blood Glucose Monitoring Systems Market Opportunities
    • 4.3.1 Strategic business activities by key players for market expansion also provide growth opportunities
    • 4.3.2 Rise in government initiatives to raise awareness in low and middle-income nations may provide an opportunity to the market

5. Blood Glucose Monitoring Systems Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Blood Glucose Monitoring Systems Market

7. Blood Glucose Monitoring Systems Market layout

  • 7.1 By Product Type
    • 7.1.1 Self-Monitoring Blood Glucose Systems
    • 7.1.2 Continuous Glucose Monitoring Systems
  • 7.2 By Modality
    • 7.2.1 Wearable
    • 7.2.2 Non-wearable
  • 7.3 By End-user
    • 7.3.1 Hospitals
    • 7.3.2 Home care settings
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 North America Blood Glucose Monitoring Systems Market, by Product Type
      • 7.4.1.2 North America Blood Glucose Monitoring Systems Market, by Modality
      • 7.4.1.3 North America Blood Glucose Monitoring Systems Market, by End User
      • 7.4.1.4 North America Blood Glucose Monitoring Systems Market, by Country
      • 7.4.1.4.1 United States
      • 7.4.1.4.2 Canada
      • 7.4.1.4.3 Mexico
    • 7.4.2 Europe
      • 7.4.2.1 Europe Blood Glucose Monitoring Systems Market, by Product Type
      • 7.4.2.2 Europe Blood Glucose Monitoring Systems Market, by Modality
      • 7.4.2.3 Europe Blood Glucose Monitoring Systems Market, by End User
      • 7.4.2.4 Europe Blood Glucose Monitoring Systems Market, by Country
      • 7.4.2.4.1 France
      • 7.4.2.4.2 Germany
      • 7.4.2.4.3 United Kingdom
      • 7.4.2.4.4 Italy
      • 7.4.2.4.5 Spain
      • 7.4.2.4.6 Russia
      • 7.4.2.4.7 Rest of Europe
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 Asia-Pacific Blood Glucose Monitoring Systems Market, by Product Type
      • 7.4.3.2 Asia-Pacific Blood Glucose Monitoring Systems Market, by Modality
      • 7.4.3.3 Asia-Pacific Blood Glucose Monitoring Systems Market, by End User
      • 7.4.3.4 Asia-Pacific Blood Glucose Monitoring Systems Market, by Country
      • 7.4.3.4.1 China
      • 7.4.3.4.2 Japan
      • 7.4.3.4.3 India
      • 7.4.3.4.4 Australia
      • 7.4.3.4.5 South Korea
      • 7.4.3.4.6 Rest of Asia Pacific
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 RoW Blood Glucose Monitoring Systems Market, by Product Type
      • 7.4.4.2 RoW Blood Glucose Monitoring Systems Market, by Modality
      • 7.4.4.3 RoW Blood Glucose Monitoring Systems Market, by End User
      • 7.4.4.4 RoW Blood Glucose Monitoring Systems Market, by Region
      • 7.4.4.1 Middle East
      • 7.4.4.2 Africa
      • 7.4.4.3 South America

8. Blood Glucose Monitoring Systems Global Company Share Analysis - Key 3-5 Companies

9. Blood Glucose Monitoring Systems Company and Product Profiles

  • 9.1 Medtronic
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Abbott
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 F. Hoffmann-La Roche Ltd
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 LifeScan IP Holdings (Johnson & Johnson)
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 Dexcom Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 ARKRAY, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 Senseonics
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 WaveForm Technologies, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 B. Braun Melsungen AG
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 Ascensia Diabetes Care Holdings AG.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 Ypsomed
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 i-SENS, Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 Intuity Medical, Inc.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 ACON Laboratories, Inc.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 Prodigy Diabetes Care, LLC
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy
  • 9.16 Sinocare
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5. Entropy
  • 9.17 Rossmax International Ltd.
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5. Entropy
  • 9.18 Menarini Diagnostics s.r.l
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4 Product Listing
    • 9.18.5. Entropy
  • 9.19 Bionime Corporation.
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4 Product Listing
    • 9.19.5. Entropy
  • 9.20 Nemaura.
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4 Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Blood Glucose Monitoring Systems Market
  • Table 3 Blood Glucose Monitoring Systems Market Analysis in Global (2021-2030)
  • Table 4 Blood Glucose Monitoring Systems Market Analysis in Global by Product Type (2021-2030)
  • Table 5 Blood Glucose Monitoring Systems Market Analysis in Global by Modality (2021-2030)
  • Table 6 Blood Glucose Monitoring Systems Market Analysis in Global by End User (2021-2030)
  • Table 7 Blood Glucose Monitoring Systems Market Analysis in Global by Geography (2021-2030)
  • Table 8 Blood Glucose Monitoring Systems Market Analysis in North America (2021-2030)
  • Table 9 Blood Glucose Monitoring Systems Market Analysis in North America by Product Type (2021-2030)
  • Table 10 Blood Glucose Monitoring Systems Market Analysis in North America by Modality (2021-2030)
  • Table 11 Blood Glucose Monitoring Systems Market Analysis in North America by End User (2021-2030)
  • Table 12 Blood Glucose Monitoring Systems Market Analysis in North America by Country (2021-2030)
  • Table 13 Blood Glucose Monitoring Systems Market Analysis in the US (2021-2030)
  • Table 14 Blood Glucose Monitoring Systems Market Analysis in Canada (2021-2030)
  • Table 15 Blood Glucose Monitoring Systems Market Analysis in Mexico (2021-2030)
  • Table 16 Blood Glucose Monitoring Systems Market Analysis in Europe (2021-2030)
  • Table 17 Blood Glucose Monitoring Systems Market Analysis in Europe by Product Type (2021-2030)
  • Table 18 Blood Glucose Monitoring Systems Market Analysis in Europe by Modality (2021-2030)
  • Table 19 Blood Glucose Monitoring Systems Market Analysis in Europe by End User (2021-2030)
  • Table 20 Blood Glucose Monitoring Systems Market Analysis in Europe by Country (2021-2030)
  • Table 21 Blood Glucose Monitoring Systems Market Analysis in France (2021-2030)
  • Table 22 Blood Glucose Monitoring Systems Market Analysis in Germany (2021-2030)
  • Table 23 Blood Glucose Monitoring Systems Market Analysis in the UK (2021-2030)
  • Table 24 Blood Glucose Monitoring Systems Market Analysis in Italy (2021-2030)
  • Table 25 Blood Glucose Monitoring Systems Market Analysis in Spain (2021-2030)
  • Table 26 Blood Glucose Monitoring Systems Market Analysis in Russia (2021-2030)
  • Table 27 Blood Glucose Monitoring Systems Market Analysis in Rest of Europe (2021-2030)
  • Table 28 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific (2021-2030)
  • Table 29 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Table 30 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific by Modality (2021-2030)
  • Table 31 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific by End User (2021-2030)
  • Table 32 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 33 Blood Glucose Monitoring Systems Market Analysis in China (2021-2030)
  • Table 34 Blood Glucose Monitoring Systems Market Analysis in Japan (2021-2030)
  • Table 35 Blood Glucose Monitoring Systems Market Analysis in India (2021-2030)
  • Table 36 Blood Glucose Monitoring Systems Market Analysis in Australia (2021-2030)
  • Table 37 Blood Glucose Monitoring Systems Market Analysis in South Korea (2021-2030)
  • Table 38 Blood Glucose Monitoring Systems Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 39 Blood Glucose Monitoring Systems Market Analysis in Rest of World (2021-2030)
  • Table 40 Blood Glucose Monitoring Systems Market Analysis in Rest of World by Product Type (2021-2030)
  • Table 41 Blood Glucose Monitoring Systems Market Analysis in Rest of World by Modality (2021-2030)
  • Table 42 Blood Glucose Monitoring Systems Market Analysis in Rest of World by End User (2021-2030)
  • Table 43 Blood Glucose Monitoring Systems Market Analysis in Rest of World by Country (2021-2030)
  • Table 44 Blood Glucose Monitoring Systems Market Analysis in the Middle East (2021-2030)
  • Table 45 Blood Glucose Monitoring Systems Market Analysis in Africa (2021-2030)
  • Table 46 Blood Glucose Monitoring Systems Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Blood Glucose Monitoring Systems Market
  • Figure 3 Blood Glucose Monitoring Systems Market Analysis in Global (2021-2030)
  • Figure 4 Blood Glucose Monitoring Systems Market Analysis in Global by Product Type (2021-2030)
  • Figure 5 Blood Glucose Monitoring Systems Market Analysis in Global by Modality (2021-2030)
  • Figure 6 Blood Glucose Monitoring Systems Market Analysis in Global by End User (2021-2030)
  • Figure 7 Blood Glucose Monitoring Systems Market Analysis in Global by Geography (2021-2030)
  • Figure 8 Blood Glucose Monitoring Systems Market Analysis in North America (2021-2030)
  • Figure 9 Blood Glucose Monitoring Systems Market Analysis in North America by Product Type (2021-2030)
  • Figure 10 Blood Glucose Monitoring Systems Market Analysis in North America by Modality (2021-2030)
  • Figure 11 Blood Glucose Monitoring Systems Market Analysis in North America by End User (2021-2030)
  • Figure 12 Blood Glucose Monitoring Systems Market Analysis in North America by Country (2021-2030)
  • Figure 13 Blood Glucose Monitoring Systems Market Analysis in the US (2021-2030)
  • Figure 14 Blood Glucose Monitoring Systems Market Analysis in Canada (2021-2030)
  • Figure 15 Blood Glucose Monitoring Systems Market Analysis in Mexico (2021-2030)
  • Figure 16 Blood Glucose Monitoring Systems Market Analysis in Europe (2021-2030)
  • Figure 17 Blood Glucose Monitoring Systems Market Analysis in Europe by Product Type (2021-2030)
  • Figure 18 Blood Glucose Monitoring Systems Market Analysis in Europe by Modality (2021-2030)
  • Figure 19 Blood Glucose Monitoring Systems Market Analysis in Europe by End User (2021-2030)
  • Figure 20 Blood Glucose Monitoring Systems Market Analysis in Europe by Country (2021-2030)
  • Figure 21 Blood Glucose Monitoring Systems Market Analysis in France (2021-2030)
  • Figure 22 Blood Glucose Monitoring Systems Market Analysis in Germany (2021-2030)
  • Figure 23 Blood Glucose Monitoring Systems Market Analysis in the UK (2021-2030)
  • Figure 24 Blood Glucose Monitoring Systems Market Analysis in Italy (2021-2030)
  • Figure 25 Blood Glucose Monitoring Systems Market Analysis in Spain (2021-2030)
  • Figure 26 Blood Glucose Monitoring Systems Market Analysis in Russia (2021-2030)
  • Figure 27 Blood Glucose Monitoring Systems Market Analysis in Rest of Europe (2021-2030)
  • Figure 28 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific (2021-2030)
  • Figure 29 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Figure 30 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific by Modality (2021-2030)
  • Figure 31 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific by End User (2021-2030)
  • Figure 32 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 33 Blood Glucose Monitoring Systems Market Analysis in China (2021-2030)
  • Figure 34 Blood Glucose Monitoring Systems Market Analysis in Japan (2021-2030)
  • Figure 35 Blood Glucose Monitoring Systems Market Analysis in India (2021-2030)
  • Figure 36 Blood Glucose Monitoring Systems Market Analysis in Australia (2021-2030)
  • Figure 37 Blood Glucose Monitoring Systems Market Analysis in South Korea (2021-2030)
  • Figure 38 Blood Glucose Monitoring Systems Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 39 Blood Glucose Monitoring Systems Market Analysis in Rest of World (2021-2030)
  • Figure 40 Blood Glucose Monitoring Systems Market Analysis in Rest of World by Product Type (2021-2030)
  • Figure 41 Blood Glucose Monitoring Systems Market Analysis in Rest of World by Modality (2021-2030)
  • Figure 42 Blood Glucose Monitoring Systems Market Analysis in Rest of World by End User (2021-2030)
  • Figure 43 Blood Glucose Monitoring Systems Market Analysis in Rest of World by Country (2021-2030)
  • Figure 44 Blood Glucose Monitoring Systems Market Analysis in the Middle East (2021-2030)
  • Figure 45 Blood Glucose Monitoring Systems Market Analysis in Africa (2021-2030)
  • Figure 46 Blood Glucose Monitoring Systems Market Analysis in South America (2021-2030)
  • Figure 47 Market Drivers
  • Figure 48 Market Barriers
  • Figure 49 Market Opportunities
  • Figure 50 PORTER's Five Force Analysis